Patent details

Basic Information

Publication number:

EP2453910

PCT Application Number:

PCT/US/2010/042015

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP107376998

PCT Publication Number:

WO/2011/008885

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

UNIT DOSE FORMULATION OF ANTIDOTE FOR FACTOR XA INHIBITORS FOR USE IN PREVENTING BLEEDING

French Title of Invention:

FORMULATION DE DOSE UNIQUE D'ANTIDOTES POUR DES INHIBITEURS DE FACTEUR XA POUR LA PRÉVENTION DE L'HEMORRAGIE

German Title of Invention:

EINZELDOSISFORMULIERUNG VON ANTIDOTEN FÜR FAKTOR-XA-HEMMER ZUR PRÄVENTION VON BLUTUNG

SPC Number:

Dates

Filing date:

14/07/2010

Grant date:

31/08/2016

EP Publication Date:

31/08/2016

PCT Publication Date:

20/01/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/05/2012

EP B1 Publication Date:

31/08/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/07/2017

Expiration date:

14/07/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/07/2010

 

 

Name:

Portola Pharmaceuticals Inc.

Address:

270 East Grand Avenue Suite 22, South San Francisco California 94080, United States (US)

Inventor

1

Name:

HOLLENBACH Stanley J.

Address:

United States (US)

2

Name:

LU Genmin

Address:

United States (US)

3

Name:

HUTCHALEELAHA Athiwat

Address:

United States (US)

4

Name:

SINHA Uma

Address:

United States (US)

Priority

Priority Number:

225887 P

Priority Date:

15/07/2009

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/48;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages